Our oncologist approved Artificial Intelligence-based engine helps match you to the best active breast cancer clinical trials near you.
Norton Cancer Institute What We Treat Anal Cancer Bile Duct Cancer Bladder Cancer Brain Cancer and Central Nervous System Tumors Breast Cancer Breast Health Program Prevention and Detection Risk Factors Diagnosis Treatment Clinical Trials Locations Rehab Services Cervical Cancer Colon Cancer Es...
The clinical treatment methods of different subtypes of breast cancer are different and related, and the achievements in the field of breast cancer clinical research are fruitful. In 2022, results of important clinical trials have achieved for different subtypes...
The OncLive Breast Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of breast cancer, including those that are triple negative, hormone receptor positive, and/or HER2 positive. This page features news articles, interviews in written and ...
Subjective health estimations (SHE) in patients with advanced breast cancer: an adapted utility concept for clinical trials. Subjective health estimations (SHE) in patients with advanced breast cancer: an adapted utility concept for clinical trials. Br J Cancer 1998; 77:985-91.Hurny C, van ...
The B-MaP-C study aimed to determine alterations to breast cancer (BC) management during the peak transmission period of the UK COVID-19 pandemic and the potential impact of these treatment decisions. This was a national cohort study of patients with ear
Breast cancer remains the leading cause of cancer death in women owing to metastasis and the development of resistance to established therapies. Macrophages are the most abundant immune cells in the breast tumor microenvironment and can both inhibit and
1. Denkert C, et al. Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials. Lancet Oncol. 2021 Aug;22(8):1151...
1. Denkert C, et al. Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials. Lancet Oncol. 2021 Aug;22(8):1151-1161. 2. Chen Z, et al. Is HER2 ultra‑low breast cancer differ...
Breast cancer is the commonest malignancy of women and with its incidence on the rise, the need to identify new targets for treatment is imperative. There is a growing interest in the role of lipid metabolism in cancer. Carnitine palmitoyl-transferase-1